Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study was to demonstrate the superiority of levodopa -
carbidopa intestinal gel over treatment with optimized oral levodopa/carbidopa during 12
weeks.
Phase:
Phase 3
Details
Lead Sponsor:
AbbVie (prior sponsor, Abbott)
Collaborator:
Quintiles, Inc.
Treatments:
Carbidopa Carbidopa, levodopa drug combination Levodopa